Next Article in Journal
Phytochemical Identification, Acute, and Sub-Acute Oral Toxicity Studies of the Foliar Extract of Withania frutescens
Previous Article in Journal
Ring-Closing Metathesis Approaches towards the Total Synthesis of Rhizoxins
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 25
Issue 19
10.3390/molecules25194525
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Actions of FTY720 (Fingolimod), a Sphingosine-1-Phosphate Receptor Modulator, on Delayed-Rectifier K+ Current and Intermediate-Conductance Ca2+-Activated K+ Channel in Jurkat T-Lymphocytes

by
Wei-Ting Chang
1,2,3,
Ping-Yen Liu
1,4 and
Sheng-Nan Wu
5,6,7,*
1
Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan
2
Division of Cardiovascular Medicine, Chi-Mei Medical Center, Tainan 71004, Taiwan
3
Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan 71004, Taiwan
4
Division of Cardiology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 70401, Taiwan
5
Department of Physiology, National Cheng Kung University Medical College, Tainan 70101, Taiwan
6
Institute of Basic Medical Sciences, National Cheng Kung University Medical College, Tainan 70101, Taiwan
7
Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 40402, Taiwan
*
Author to whom correspondence should be addressed.
Molecules 2020, 25(19), 4525; https://doi.org/10.3390/molecules25194525
Submission received: 5 September 2020 / Revised: 25 September 2020 / Accepted: 30 September 2020 / Published: 2 October 2020
(This article belongs to the Section Electrochemistry)
Browse Figures
Review Reports Versions Notes

Abstract

FTY720 (fingolimod), a modulator of sphingosine-1-phosphate receptors, is known to produce the immunomodulatory actions and to be beneficial for treating the relapsing multiple sclerosis. However, whether it exerts any effects on membrane ion currents in immune cells remains largely unknown. Herein, the effects of FTY720 on ionic currents in Jurkat T-lymphocytes were investigated. Cell exposure to FTY720 suppressed the amplitude of delayed-rectifier K+ current (IK(DR)) in a time- and concentration-dependent manner with an IC50 value of 1.51 μM. Increasing the FTY720 concentration not only decreased the IK(DR) amplitude but also accelerated the inactivation time course of the current. By using the minimal reaction scheme, the effect of FTY720 on IK(DR) inactivation was estimated with a dissociation constant of 3.14 μM. FTY720 also shifted the inactivation curve of IK(DR) to a hyperpolarized potential with no change in the slope factor, and recovery from IK(DR) became slow during the exposure to this compound. Cumulative inactivation for IK(DR) in response to repetitive depolarizations was enhanced in the presence of FTY720. In SEW2871-treated cells, FTY720-induced inhibition of IK(DR) was attenuated. This compound also exerted a stimulatory action on the activity of intermediate-conductance Ca2+-activated K+ channels in Jurkat T-lymphocytes. However, in NSC-34 neuronal cells, FTY720 did not modify the inactivation kinetics of KV3.1-encoded IK(DR), although it suppressed IK(DR) amplitude in these cells. Collectively, the perturbations by FTY720 on different types of K+ channels may contribute to the functional activities of immune cells, if similar findings appear in vivo.

Graphical Abstract

1. Introduction

FTY720 (Fingolimod, Glienya®, 2-Amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol) is a potent immunosuppressive agent that was originally derived from myriocin, a sphingosine-like fungal metabolite [1,2]. This compound is thought to possess encouraging efficacy profiles in different experimental autoimmune disorders and for the treatment of multiple sclerosis [1,3,4]. From another perspective, FTY720 can act to work through its binding to S1P receptor subtype 1 (S1P1), which can prevent the egress of lymphocytes from lymph nodes [5,6]. However, it is unclear whether this compound exerts its effect as a regulator of ion channels [7,8]. The KV1.3-encoded currents, which exhibit unique gating properties and voltage dependency, largely constitute the delayed-rectifier K+ currents (IK(DR) enriched in immune cells [9,10,11]. These currents, which can be functionally expressed in the plasma membrane and the inner mitochondrial membrane, have been demonstrated to perform key functions in the immune system such as lymphocyte activation [10,11,12,13,14,15]. In particular, the KV1.3 phenotype has been previously demonstrated to be specifically expressed in ion myelin-specific activated cells from patients with multiple sclerosis and not detected in T cells activated with other antigens [16]. KV1.3+ cells secrete considerable amounts of interferon-γ and tumor necrotic factor-α [17] and KV1.3 inhibitors potently suppress experimental autoimmune encephalitis [18,19]. The inhibitors of KV1.3 channels indeed represent a potentially therapeutic approach to the diseases including multiple sclerosis [2,4,15]. Additionally, it was noticed that the activity of intermediated-conductance Ca2+-activated K+ channels (i.e., KCa3.1-encoded channels) was functionally expressed in immune cells [20,21].
The Jurkat T cell line is a CD45-deficient clone derived from the E6-1 clone of the Jurkat human T-cell leukemic cell line, and it has been previously demonstrated to express KV1.3-type IK(DR) [9,11,20]. This cell line is recognized as a suitable model for investigations of lymphocytic functions such as cellular activation and apoptosis [12]. The macroscopic IK(DR) in Jurkat T lymphocytes is encoded by KCNA3 gene giving rise to a native KV1.3 channel [9]. In these cells, recent studies have also demonstrated the presence of KV1.3 channels in the inner mitochondrial membrane, which is strongly linked to lymphocyte apoptosis because of the Bax-KV1.3 interaction [12,21,22,23].
Therefore, the goal of this study was to evaluate the effect of FTY720 on ionic current in Jurkat T-lymphocytes, particularly at IK(DR) and IKCa channels. Unexpectedly, in these cells, we found that FTY720 not only diminished the peak amplitude of IK(DR) (KV1.3-encoded current) but also shortened the time course of current inactivation in response to rapid membrane depolarization. Additionally, this agent was also effective at increasing the activity of IKCa channels in Jurkat T-lymphocytes. Therefore, it is anticipated that those actions caused by FTY720 may synergistically act to influence the recognition processes and subsequently to perturb the functional activities of immune cells and the immunological synapses in cell culture or in vivo [20,24].

2. Results

2.1. Inhibitory Effect of FTY720 on Delayed-Rectifier K+ Current (IK(DR)) Measured from Jurkat T-Lymphocytes

In this study, we initially evaluated the effect of FTY720 on IK(DR) in Jurkat T-lymphocytes under whole-cell current recordings. As Jurkat cells were bathed in Ca2+-free Tyrode’s solution, the IK(DR) in response to a 1-sec ramp voltage-clamp pulse from −90 to +90 mV could be readily elicited. This population of K+ currents has been previously identified as IK(DR) and to resemble the KV1.3-encoded currents [9,10,11]. After cells were exposed to FTY720 at different concentrations, the amplitude of IK(DR) evoked by the 1-sec long ramp pulse became progressively decreased (Figure 1). For example, at the level of +60 mV, FTY720 at a concentration of 3 μM significantly reduced IK(DR) amplitude by 61 ± 3 % from 298 ± 13 to 122 ± 8 pA (n = 11, P < 0.05). After the washout of FTY720, the current amplitude returned to 282 ± 11 pA (n = 7). Additionally, nonactin (10 μM), a K+-selective neutral ionophore [25], could reverse FTY720-mediated inhibition of IK(DR) seen in Jurkat T-lymphocytes.
The relationship between the FTY720 concentration and the relative amplitude of IK(DR) was determined and then constructed. In these experiments, the examined cell was held at −50 mV, the ramp pulse from −90 to +90 mV with a duration of 1 sec was applied, and the IK(DR) amplitudes were measured at the level of +60 mV in the presence of different FTY720 concentrations. As illustrated in Figure 1, FTY720 suppressed IK(DR) amplitude in a concentration-dependent manner. By virtue of a non-linear least-squares fit to the data [26,27,28], the IC50 value required for the inhibitory effect of FTY720 on IK(DR) in Jurkat T-lymphocytes was calculated to be 1.51 μM. These results reflect that FTY is capable of exerting a depressant action on IK(DR) in these cells.

2.2. Kinetic Studies of FTY720-Induced Block of IK(DR)

Because the IK(DR) inactivation in response to rapid and long-lasting depolarization tends to be enhanced (Figure 2), it is pertinent to evaluate the kinetics of FTY720-induced block seen in Jurkat T-lymphocytes. As illustrated in Figure 2, when cells were rapidly depolarized from −50 to +50 mV with a duration of 1 sec, it can be noted that exposure to FTY720 produced a reduction in the τinact value in a concentration-dependent fashion. Therefore, findings from these results strongly suggest that inhibitory effects of FTY720 on IK(DR) in Jurkat T-lymphocytes can be explained in a satisfactory way by the state-dependent blocking where it can bind to the open state of the channel according to the first-order blocking scheme: Molecules 25 04525 i001 where α and β are kinetic constants for the opening and closing of KV channel, and k+1 and k−1 are those for forward and reverse rate constants of the FTY720 binding. “Closed”, “Open”, and “Inactivated” represent the closed, open, and inactivated states of the channel, respectively. Forward and reverse rate constants, k+1 and k−1, were estimated from the values of τinact for FTY720-induced modification in the trajectory of IK(DR) inactivation (Figure 2). In agreement with the kinetic scheme described under Materials and Methods, the relationship between k+1 and [B] was noted to become linear with a correlation coefficient of 0.96 (Figure 2C). The forward and reverse rate constants obtained from 8 to 10 different cells were calculated to be 1.0046 sec−1μM−1 and 3.1558 sec−1, respectively. On the basis of these rate constants, a value of 3.14 μM for the dissociation constant (KD = k−1/k+1) of this compound was derived. This value was found to be in agreement with the IC50 value determined by the concentration-response curve (Figure 1B).

2.3. Steady-State Inactivation of IK(DR) During the Exposure to FTY720

To further characterize the inhibitory effect of FTY720 on IK(DR), we next investigated the voltage dependence of the effect of FTY720 on IK(DR) in Jurkat T-lymphocytes by using a two-step voltage protocol. Figure 3 illustrates the steady-state inactivation curve of IK(DR) with or without the addition of 3 μM FTY720. In these experiments, a 1-sec conditioning pulse to different potentials preceded the test pulse to +50 mV from a holding potential of −50 mV. The relationship between the conditioning potentials and the normalized amplitudes of peak IK(DR) were constructed and fitted with a Boltzmann function, as described in Materials and Methods. In the control (i.e., in the absence of FTY720), the voltages for half-maximal inactivation (V1/2) and corresponding slope factor (k) were −5.4 ± 0.2 mV and 5.31 ± 0.02 mV (n = 9), respectively, while in the presence of 3 μM FTY720, the values of V1/2 and k were -18.5 ± 0.9 mV and 5.32 ± 0.02 mV (n = 8), respectively. It is clear from these results that the addition of FTY720 (3 μM) significantly shifted the midpoint of the inactivation curve toward hyperpolarizing voltage by approximately 13 mV (P < 0.05); however, no discernible change in the slope factor (i.e., k) was observed in the presence of this compound. Therefore, in Jurkat T-lymphocytes, there was a voltage-dependence of the steady-state inactivation curve of IK(DR) during cell exposure to FTY720.

2.4. Effect of FTY720 on the Recovery of IK(DR) from Inactivation

The effect of FTY720 on the recovery of IK(DR) from inactivation was further determined with another two-pulse protocol consisting of a first (conditioning) depolarizing pulse, which was enough to enable the block to reach a steady state. In this set of experiments, the membrane potential was initially taken to +50 mV from −50 mV for a duration of 150 msec, after which a second depolarizing pulse (test pulse) was then applied at the same potential as the conditioning pulse (Figure 4). The ratios of the peak amplitude of IK(DR) evoked in the response to the test and the conditioning pulses were then determined as a measure of recovery from block, and plotted against the interpulse interval. As depicted in Figure 4, the time course of recovery from inactivation in the control was fitted to a single exponential function with a time constant of 1.8 ± 0.1 sec (n = 9). As FTY720 at a concentration of 1 and 3 μM was applied, the time constant was significantly prolonged to 3.1 ± 0.2 (n = 7, P < 0.05) and 4.8 ± 0.2 sec (n = 7, P < 0.05). Therefore, the recovery of IK(DR) from inactivation observed in Jurkat T-lymphocytes clearly became slowed in the presence of FTY720. The delayed recovery of IK(DR) caused by FTY720 was most likely due to the open channel block.

2.5. FTY720-Induced Increase in Cumulative Inhibition of IK(DR) Inactivation

In another set of experiments, we sought to determine whether FTY720 can alter the time course of IK(DR) inactivation in response to repetitive stimuli in Jurkat T-lymphocytes. Under control condition, a single 1-sec depolarizing step to +50 mV from a holding potential produced an exponential decline with a time constant of 352 ± 12 msec (n = 11). However, the time constant for 1-sec repetitive pulses to +50 mV, each of which lasted 40 msec with 10-msec interval at −50 mV between the depolarizing pulses, was significantly reduced to 326 ± 11 msec (n = 10). Moreover, as depicted in Figure 5, there was a progressive increase in the decline of IK(DR) in response to rapid depolarizing stimuli. As the cells were exposed to FTY720, the value of time constant taken from such train of short repetitive pulses was further decreased. The addition of 1 and 3 μM FTY720 significantly decreased the time constant to 212 ± 8 msec (n = 8, P < 0.05) and 156 ± 8 msec (n = 8, P < 0.05), respectively. Therefore, findings from these results indicate that an excessive accumulative inactivation of IK(DR) during cell exposure to FTY720 can be detected.

2.6. Effect of FTY720 on IK(DR) in Jurkat T-Lymphocytes Treated with SEW2781

FTY720 was recognized to be an agent involving modulation of S1P receptors on lymphocytes [5,6]. We next evaluate whether binding to the S1P receptor can influence the FTY720-induced block of IK(DR) in Jurkat T-lymphocytes. In this set of experiments, Jurkat cells were preincubated with SEW2871 (3 μM) for 5 h. SEW2871 is a selective agonist of the S1P1 receptor [29]. In SEW2871-treated cells, the inhibitory effect of FTY720 on IK(DR) was attenuated (Figure 6). Distinguishable from the results from control cells (i.e., SEW2871 was not pre-treated), the inactivation time course of IK(DR) remained unaltered in the presence of FTY720. Similar actions occurred in Jurkat T-lymphocytes treated with S1P (10 μM). The magnitude of FTY720-induced inhibition of IK(DR) was diminished with no modification in activation or inactivation kinetics of this current. These results led us to propose that the inhibitory effect of FTY720 on IK(DR) in these cells tends to be associated with its binding to the S1P1 receptor.

2.7. Stimulatory Effect of FTY720 on the Activity of IKCa Channels in Jurkat T-Lymphocytes

In another set of experiments, we sought to determine whether FTY720 exerts any effect on the activity of IKCa channels in these cells. Cell-attached current recordings were performed and cells were bathed in high K+-solution containing 1.8 mM CaCl2. As shown in Figure 7, under our experimental conditions, the activity of IKCa channels, which was sensitive to block by TRAM-34 and to stimulation by 9-phenanthrol, was readily detected as described previously in different types of cells [25,30,31]. As FTY720 was applied to the bath, the probability of IKCa-channel openings was progressively raised. For example, the addition of FTY720 at a concentration of 1 and 3 μM significantly increased the channel open probability measured at -60 mV to 0.0035 ± 0.007 and 0.0047 ± 0.009, respectively, from control of 0.0013 ± 0.0005 (n = 11, P < 0.05). Conversely, no clear change in single-channel conductance of IKCa channels was found in the presence of FTY720 (48 ± 2 pS [control] versus 49 ± 2 pS [3 μM FTY720], n = 9, P > 0.05). In the continued presence of FTY720 (3 μM), subsequent addition of TRAM-34 (1 μM) reversed the probability of channel openings, as evidenced by the significant decrease of channel activity to 0.0018 ± 0.0005 (n = 9, P < 0.05). However, paxilline (1 μM), known to be a blocker of BKCa channels, did not produce any effect on FTY720-induced increase of IKCa-channel activity. Therefore, apart from the inhibition of IK(DR), FTY720 is effective at stimulating the activity of IKCa channels in Jurkat T-lymphocytes.

2.8. Effect of FTY720 on IK(DR) Recorded from NSC-34 Neuronal Cells

In a final set of experiments, we further investigated whether this compound had any effect on IK(DR) in other types of cells (e.g., NSC-34 neuronal cells). Cells were bathed in Ca2+-free Tyrode’s solution containing 1 μM tetrodotoxin and 0.5 mM CdCl2 and the recording pipette was filled with K+-containing solution. Tetrodotoxin and CdCl2 were used to block Na+ and Ca2+ currents, respectively. Under this condition, the macroscopic IK(DR) in response to membrane depolarization has been previously described in these cells and identified primarily as KV3.1-encoded current [32]. Unexpectedly, when cells were exposed to FTY720 (3 μM), the amplitude of IK(DR) was slightly decreased; however, neither activation nor inactivation time course of IK(DR) in response to membrane depolarization was changed in its presence (Figure 8). These data are clearly distinguishable from those observed in Jurkat T-lymphocytes described above.

3. Discussion

In this study, we provide the evidence to show that in Jurkat T-lymphocytes, FTY720 produces an inhibitory effect on IK(DR) in a concentration-, voltage- and state-dependent fashion. According to both the concentration-dependent relationship and minimal reaction scheme described herein, the values of IC50 and KD required for FTY720-mediated inhibition of IK(DR) were measured from Jurkat T-lymphocytes were calculated to be 1.51 and 3.14 μM, respectively. The steady-state inactivation curve of IK(DR) in the presence of FTY720 (3 μM) produced a leftward shift by approximately 13 mV, indicating that such inhibitory action is voltage-dependent. There might thus be a pertinent link between its effects on lymphocytes and the inhibitory effect on IK(DR) (i.e., KV1.3-encoded current). However, whether the ability of this compound to suppress mitochondrial KV1.3-encoded channels and to perturb the Bax-KV1.3 interaction [21,22,23] has yet to be clearly demonstrated.
The rate of IK(DR) inactivation was considerably enhanced as the FTY720 concentration increased. In our study, recovery from inactivation in the presence of FTY720 apparently became slow, because more than 10 sec was required for the channel to recover completely. It is thus possible that KV1.3 channel, once open, can be subsequently plugged by the FTY720 molecule in solution. Assuming that periodical changes in membrane potential of inner mitochondrial membranes may occur [33], the issue of whether blockade of mitochondrial KV1.3 channels caused by FTY720 is responsible for its effects on Bax-KV1.3 interactions [21,22,23] is worthy of being investigated. FTY720 has indeed been reported to mediate cytochrome c release from mitochondria in rat thymocytes [34]. Nonetheless, because of the importance of IK(DR) (i.e., KV1.3-encoded current) in contributing to functional activities of lymphocytes such as apoptosis [12,34], the effects of FTY720 presented herein could provide novel insights into pharmacological or immunological properties of FTY720 and other structurally related compounds [15,35].
After daily administration of FTY720 over 1 week (5 mg/day), the blood concentration of FTY720 could be around 18.2 ng/mL (0.053 μM) [36]. Together with a quantitative description of the inactivation time course of IK(DR) in response to rapid depolarization during cell exposure to different FTY720 concentrations, our results provide the evidence to indicate the FTY720 molecule can act as a state-dependent open-channel blocker of KV channels enriched in Jurkat T-lymphocytes. Any changes of IK(DR) amplitude or kinetics caused by FTY720 depend not only on the FTY720 concentration given, but also on membrane potential and intracellular Ca2+ concentrations. The inhibitory effect of FTY720 on the amplitude and gating of IK(DR) in lymphocytes may thus occur at a concentration achievable in humans. However, this compound exerted a slight inhibition of KV3.1-encoded IK(DR) and did not modify the inactivation kinetics of this current in NSC-34 neuronal cells.
FTY720 is recognized as a modulator of S1P receptors. In this study, in Jurkat T-lymphocytes preincubated with either SEW2871 or S1P, the magnitude of FTY-induced block of IK(DR) was diminished with no change in activation or inactivation kinetics of this current. SEW2871 was previously reported to be an agonist of the S1P1 receptor [29]. It is thus tempting to speculate that FTY720-mediated changes in the amplitude and gating of IK(DR) are strongly linked to its binding to S1P receptors inherently in Jurkat cells. In Coppi and colleagues’ work, through inhibiting potassium currents and positively modulating S1P synthesis, A2B receptor (A2BR) suppressed cell differentiation in cultured oligodendrocytes progenitor cells [37]. S1P inhibits delayed rectifier potassium current of guinea pigs’ ventricular myocytes. Nevertheless, there is no previous literature reporting the effects of S1P on IK(DR) of immune cells which may potentially contribute to the immune-modulation. Alternatively, whether the presence of FTY720 can perturb ionic currents in lymphocytes derived from KV1.3 null mice remains to be interestingly explored.
Another noteworthy finding in this study is that in Jurkat T-lymphocytes, the activity of IKCa (or KCNN4-encoded) channels was functionally expressed and subject to stimulation by 9-phenanthrol and to inhibition by TRAM-34 [25,30,31,38]. Additionally, the exposure to FTY720 was effective at enhancing the activity of IKCa channels with no change in the single-channel conductance of these channels. TRAM-34, still in the continued presence of FTY720, suppressed FTY720-mediated increase of IKCa-channel activity; however, paxilline did not exert any effect on FTY720-induced stimulation of IKCa channels. Consistent with previous observations in neutrophils [39,40], we found that the activity of BKCa channels was absent in Jurkat T-lymphocytes. However, to what extent FTY720-induced activation of IKCa channels found in this study is capable of exerting its effects on the activity of T lymphocytes remains to be further investigated.
Additionally, in this study, the KV3.1-encoded current, most of which constitute IK(DR) in NSC-34 neuronal cells, was relatively insensitive to blocking by FTY720. Neither the activation nor inactivation time course of IK(DR) in NSC-34 cells was altered during the exposure to FTY720. FTY720-induced effects on the amplitude and gating of KV1.3-encoded IK(DR) observed in Jurkat T-lymphocytes thus tends to be selective and can have therapeutic relevance.
In human T-lymphocytes, cell exposure to FTY720 also suppressed IK(DR) amplitude as well as shortened the inactivation time course of the current. The FTY720-induced inhibition of IK(DR) was attenuated post the treatment of SEW2871. It speculated that FTY720-mediated changes in the amplitude and gating of IK(DR) are associated with its binding to S1P receptors inherently. The graphic abstract summarized the major findings that through perturbing different types of K+ channels FTY720 may contribute to the functions of immune cells and result in an immune-modulating effect. Taken together, despite the detailed mechanism of FTY720 actions on these KV channels being unclear, if similar findings are experimentally made in lymphocytes occurring in cell culture or in vivo to those presented herein, the additional actions of FTY720 or its structurally related agents described here will result in significant additional changes in immune reactions [3,5,15]. Since this compound is regarded as an immune modulator [6,7], the FTY720-perturbed effects on ionic currents demonstrated herein could potentially participate in various clinical disorders, such as multiple sclerosis.

4. Materials and Methods

4.1. Drugs and Solutions

FTY720 (Fingolimod, Gilenya®, 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol hydrochloride, C19H33NO2), phytohemagglutinin (PHA), sphingosine-1-phosphate (S1P), tetrodotoxin and trypan blue were obtained from Sigma-Aldrich (St. Louis, MO, USA), nonactin, 9-phenanthrol, SEW2871 (5-[4-phenyl-5-(trifluoromethyl)thiophen-2-yl]-3-[3-(trifluoromethyl)phenyl]1,2,4-oxadiazole) and TRAM-34 (1-((2-chlorophenyl)(diphenyl))methyl)-1H-pyrazole) were from Tocris Cookson Ltd. (Bristol, UK), and paxilline was from Alomone Labs (Jerusalem, Israel). Chlorotoxin and margatoxin were kindly provided by Dr. Woei-Jer Chuang, (Department of Biochemistry, National Cheng Kung University Medical College, Tainan, Taiwan). Tissue culture media, fetal bovine serum (FBS), L-glutamine, trypsin/EDTA and penicillin-streptomycin were obtained from Invitrogen (Carlsbad, CA, USA). All other chemicals including CdCl2 were commercially available and of reagent grade. The twice-distilled water that had been de-ionized through a Milli-Q water purification system (APS Water Services Inc., Van Nuys, CA, USA) was used in all experiments.
The composition of normal Tyrode’s solution was 136.5 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.53 mM MgCl2, 5.5 mM glucose, and 5.5 mM HEPES-NaOH buffer; pH 7.4. To measure whole-cell K+ currents or membrane potential, a patch pipette was filled with the following solution: 140 mM KCl, 1 mM MgCl2, 3 mM Na2ATP, 0.1 mM Na2GTP, 0.1 mM EGTA, and 5 mM HEPES-KOH buffer; pH 7.2. To avoid possible contamination of Cl− currents, Cl− ions inside the pipette solution was replaced with aspartate. For the recordings of BKCa- or IKCa-channel activity, a high K+-bathing solution contained 145 mM KCl, 0.53 mM MgCl2, and 5 mM HEPES-KOH buffer; pH 7.4, and the pipette solution contained 145 mM KCl, 2 mM MgCl2 and 5 mM HEPES-KOH buffer; pH 7.2.

4.2. Cell preparations

The Jurkat T cell line, a human T cell lymphoblast-like cell line (clone E6-1), was obtained from the Bioresource Collection and Research Center (BCRC-60255; Hsinchu, Taiwan). Cells were routinely grown in a RPMI-1640 medium supplemented with 10% heat-inactivated FBS (v/v), 100 U/mL penicillin and 10 μg/mL streptomycin. They were maintained at 37 °C in a 95% air and 5% CO2 humidified atmosphere. In a separate set of experiments, Jurkat T-lymphocytes were incubated with S1P (10 μM) or SEW2871 (3 μM) at 37 °C for 5 h. NSC-34 neuronal cells were produced by the fusion of motor neuron-enriched, embryonic mouse spinal cords with mouse neuroblastoma. They were maintained in a 1:1 mixture of DMEM and Ham’s F12 medium supplemented with 10% FBS and 1% penicillin-streptomycin. To slow cell proliferation and enhance their maturation towards a differentiated state, before confluence, NSC-34 cells were grown in 1:1 DMEM plus Ham’s F12 medium supplemented with 1% FBS for 48 h. The viability of these cells was often evaluated by the trypan blue-exclusion test. The experiments were made five or six days after cells had been cultured (60–80% confluence).
For preparations of human T-lymphocytes, CD3+ and CD4+ lymphocytes were isolated from healthy donors by E-rosetting (StemCell Technology, Vancouver, BC, Canada) and Ficoll-Plaque density-gradient centrifugation (ICN Biomedicals, Aurora, OH, USA). Freshly isolated human T-lymphocytes were preactivated with 4 μg/mL PHA for about four hours. Blood intended for isolation of T-lymphocytes was obtained from healthy volunteers.

4.3. Electrophysiological Measurements

Jurkat T-lymphocytes or NSC-34 neuronal cells were harvested with 1% trypsin/EDTA solution prior to the experiments and a small aliquot of cell suspension was transferred to a home-made recording chamber positioned on the stage of a DM-IL inverted microscope (Leica Microsystems, Wetzlar, Germany) coupled to digital video system (DCR-TRV30; Tokyo, Japan) with a magnification of up to 1500×. Cells were immersed at room temperature (20–25 °C) in normal Tyrode’s solution containing 1.8 mM CaCl2. The recording pipettes were pulled from Kimax-51 glass capillaries (#34500; Kimble Glass, Vineland, NJ) using either a PP-83 puller (Narishige, Tokyo, Japan) or a horizontal puller (Sutter Instruments model P-97; Novato, CA, USA), and their tips were then fire-polished with a microforge (MF-83; Narishige). As the pulled pipettes were filled with different internal solutions described above, their resistance commonly ranged between 3 and 5 MΩ. During each experiment, the pipette mounted maneuvered by using a WR-98 hydraulic micromanipulator (Narishige, Amityville, NY, USA). Current signals recorded under cell-attached, inside-out, or whole-cell configuration were measured with the standard patch-clamp technique by use of either an RK-400 amplifier (Bio-Logic, Claix, France) or an Axopatch-200B amplifier (Molecular Devices, Sunnyvale, CA, USA) [11,25]. Liquid junction potential existing between the internal pipette solution and the extracellular medium was corrected immediately before seal formation was made.

4.4. Data Recordings

The signals, consisting of potential and current traces, were stored online on a TravelMate-6253 laptop computer (Acer, Taipei, Taiwan) at 10 kHz through a Digidata-1550A interface (Molecular Devices). During the experiments, the latter device is controlled by pCLAMP 10.2 software (Molecular Devices, San Jose, CA, USA). Current signals were low-pass filtered at 3 kHz. Through digital-to-analogue conversion, the voltage-step profiles of rectangular or ramp pulses created from pCLAMP 10.2 were commonly used to determine the current–voltage (I–V) relations for different types of ionic currents (e.g., IK(DR)). Some signals digitally stored through either wired USB or wireless Bluetooth were further analyzed using different analytical tools which include OriginPro 2016 (OriginLab, Northampton, MA, USA), Labchart 7.0 program (AD Instruments; Gerin, Tainan, Taiwan) and custom-made macros built in an Excel 2013 spreadsheet under Windows 7 (Microsoft, Redmond, WA, USA). The details of data analyses were listed in Supplementary Materials.

4.5. Analyses of Single IKCa-channel Currents

Single BKCa- or IKCa-channel currents were analyzed using pCLAMP 10.2 software (Molecular Devices, San Jose, CA, USA). Single-channel amplitudes were determined by fitting Gaussian distributions to the amplitude histograms of the closed and open states. The probabilities of channel openings were broadly estimated using an iterative process to minimize the χ2 values calculated with a sufficiently large number of independent events. Channel activity was defined as N·PO, the product of the channel number (N) and open probability (PO). Single-channel conductance of IKCa channels with or without the addition of FTY720 was determined by linear regression using mean values of current amplitudes measured at different potentials. The lifetime distributions of open or closed states were fitted with logarithmically scaled bin width [25].

4.6. Statistical Analyses

By using the least-squares minimization procedure [26], linear or nonlinear curve-fitting to experimental data in this study was performed with pCLAMP 10.2 (Molecular Devices, San Jose, CA, USA), the “Solver” add-in bundled with Excel 2013 (Microsoft, Redmond, WA, USA), or OriginPro 2016 (OriginLab, Northampton, MA, USA). The macroscopic and single-channel current data are expressed as the mean ± SEM with sample sizes (n) indicating the number of cells from which the results were taken, and error bars are plotted as SEM. The paired or unpaired Student’s t-test and one-way analysis of variance of the least-significant-difference method for multiple comparisons were used to evaluate the statistical difference among means. Statistical analyses were performed using IBM SPSS version 20.0 (IBM Corp., Armonk, NY, USA). A P value of less than 0.05 was considered to indicate the statistical difference.

Supplementary Materials

The details of data analyses were listed in supplement materials which are available online.

Author Contributions

Conceptualization, W.-T.C. and S.-N.W.; methodology, S.-N.W.; software, S.-N.W.; validation, W.-T.C., P.-Y.L. and S.-N.W.; formal analysis, S.-N.W.; investigation, W.-T.C. and S.-N.W.; resources, P.-Y.L. and S.-N.W.; data curation, S.-N.W.; writing—original draft preparation, S.-N.W.; writing—review and editing, W.-T.C. and S.-N.W.; visualization, W.-T.C., P.-Y.L. and S.-N.W.; supervision, S.-N.W.; project administration, S.-N.W.; funding acquisition, P.-Y.L. and S.-N.W. All authors have read and agreed to the published version of the manuscript.

Funding

The present study was funded by Ministry of Science and Technology (MOST-108-2314-B-006-094; 108-2628-B-384 -002), Taiwan and National Health Research Institute (NHRI-EX106-10618SC).

Acknowledgments

The authors would like to thank Yan-Ming Huang and Hui-Zhen Chen for the earlier experiments. The work in this laboratory was partly supported by a grant from National Cheng Kung University (D104-35A16), Tainan City, Taiwan.

Conflicts of Interest

The authors declare no competing interests that are directly relevant to this study.

Abbreviations

BKCa channellarge-conductance Ca2+-activated K+ channel
DMEMDulbecco’s modified Eagle’s medium
FBSfetal bovine serum
IC50the concentration required for 50% inhibition
IKCa channelintermediate-conductance Ca2+-activated K+ channel
IK(DR)delayed-rectifier K+ current
I-Vcurrent versus voltage
KDdissociation constant
KV channelvoltage-gated K+ channel
PHAphytohemagglutinin
S1Psphingosine-1-phosphate
SEMstandard error of the mean
τinactinactivation time constant

References

  1. Fujita, T.; Inoue, K.; Yamamoto, S.; Ikumoto, T.; Sasaki, S.; Toyama, R.; Chiba, K.; Hoshino, Y.; Okumoto, T. Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite. J. Antibiot. 1994, 47, 208–215. [Google Scholar] [CrossRef] [PubMed]
  2. Gonsette, R.E. New immunosuppressants with potential implication in multiple sclerosis. J. Neurol. Sci. 2004, 223, 87–93. [Google Scholar] [CrossRef] [PubMed]
  3. Yang, Z.; Chen, M.; Fialkow, L.B.; Ellett, J.D.; Wu, R.; Brinkmann, V.; Nadler, J.L.; Lynch, K.R. The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic mice. Clin. Immunol. 2003, 107, 30–35. [Google Scholar] [CrossRef]
  4. Fox, E.J. Emerging oral agents for multiple sclerosis. Am. J. Manag. Care 2010, 16, 219–226. [Google Scholar]
  5. Morris, M.A.; Gibb, D.R.; Picard, F.; Brinkmann, V.; Straume, M.; Ley, K. Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720. Eur. J. Immunol. 2005, 35, 3570–3580. [Google Scholar] [CrossRef]
  6. Brinkmann, V. FTY720 (fingolimod) in Multiple Sclerosis: Therapeutic effects in the immune and the central nervous system. Br. J. Pharmacol. 2009, 158, 1173–1182. [Google Scholar] [CrossRef]
  7. Koyrakh, L.; Roman, M.I.; Brinkmann, V.; Wickman, K. The heart rate decrease caused by acute FTY720 administration is mediated by the G protein-gated potassium channel I. Am. J. Transplant. 2005, 5, 529–536. [Google Scholar] [CrossRef]
  8. Ochi, R.; Momose, Y.; Oyama, K.; Giles, W.R. Sphingosine-1-phosphate effects on guinea pig atrial myocytes: Alterations in action potentials and K+ currents. Cardiovasc. Res. 2006, 70, 88–96. [Google Scholar] [CrossRef]
  9. Gasiorowska, J.; Teisseyre, A.; Uryga, A.; Michalak, K. Inhibition of Kv1.3 Channels in Human Jurkat T Cells by Xanthohumol and Isoxanthohumol. J. Membr. Biol. 2015, 248, 705–711. [Google Scholar] [CrossRef]
  10. Gilhar, A.; Bergman, R.; Assay, B.; Ullmann, Y.; Etzioni, A. The beneficial effect of blocking Kv1.3 in the psoriasiform SCID mouse model. J. Invest. Dermatol. 2011, 131, 118–124. [Google Scholar] [CrossRef]
  11. Wu, S.N.; Chen, B.S.; Lo, Y.C. Evidence for aconitine-induced inhibition of delayed rectifier K(+) current in Jurkat T-lymphocytes. Toxicology 2011, 289, 11–18. [Google Scholar] [CrossRef]
  12. Gulbins, E.; Sassi, N.; Grassme, H.; Zoratti, M.; Szabo, I. Role of Kv1.3 mitochondrial potassium channel in apoptotic signalling in lymphocytes. Biochim. Biophys. Acta 2010, 1797, 1251–1259. [Google Scholar] [CrossRef]
  13. Kazama, I. Roles of lymphocyte Kv1.3-channels in gut mucosal immune system: Novel therapeutic implications for inflammatory bowel disease. Med. Hypotheses 2015, 85, 61–63. [Google Scholar] [CrossRef]
  14. Hansen, L.K.; Sevelsted-Møller, L.; Rabjerg, M.; Larsen, D.; Hansen, T.P.; Klinge, L.; Wulff, H.; Knudsen, T.; Kjeldsen, J.; Köhler, R. Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis. J. Crohns Colitis 2014, 8, 1378–1391. [Google Scholar] [CrossRef]
  15. RamaKrishnan, A.M.; Sankaranarayanan, K. Understanding autoimmunity: The ion channel perspective. Autoimmun. Rev. 2016, 15, 585–620. [Google Scholar] [CrossRef]
  16. Wulff, H.; Calabresi, P.A.; Allie, R.; Yun, S.; Pennington, M.; Beeton, C.; Chandy, K.G. The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS. J. Clin. Invest. 2003, 111, 1703–1713. [Google Scholar] [CrossRef] [PubMed]
  17. Geginat, J.; Sallusto, F.; Lanzavecchia, A. Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. J. Exp. Med. 2001, 194, 1711–1719. [Google Scholar] [CrossRef] [PubMed]
  18. Beeton, C.; Barbaria, J.; Giraud, P.; Devaux, J.; Benoliel, A.M.; Gola, M.; Sabatier, J.M.; Bernard, D.; Crest, M.; Béraud, E. Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation. J. Immunol. 2001, 166, 936–944. [Google Scholar] [CrossRef] [PubMed]
  19. Beeton, C.; Wulff, H.; Barbaria, J.; Clot-Faybesse, O.; Pennington, M.; Bernard, D.; Cahalan, M.D.; Chandy, K.G.; Béraud, E. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc. Natl. Acad. Sci. USA 2001, 98, 13942–13947. [Google Scholar] [CrossRef] [PubMed]
  20. Panyi, G.; Bagdany, M.; Bodnar, A.; Vamosi, G.; Szentesi, G.; Jenei, A.; Matyus, L.; Varga, S.; Waldmann, T.A.; Gaspar, R.; et al. Colocalization and nonrandom distribution of Kv1.3 potassium channels and CD3 molecules in the plasma membrane of human T lymphocytes. Proc. Natl. Acad. Sci. USA 2003, 100, 2592–2597. [Google Scholar] [CrossRef] [PubMed]
  21. Szabó, I.; Bock, J.; Grassmé, H.; Soddemann, M.; Wilker, B.; Lang, F.; Zoratti, M.; Gulbins, E. Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes. Proc. Natl. Acad. Sci. USA 2008, 105, 14861–14866. [Google Scholar] [CrossRef]
  22. Leanza, L.; Henry, B.; Sassi, N.; Zoratti, M.; Chandy, K.G.; Gulbins, E.; Szabò, I. Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells. EMBO Mol. Med. 2012, 4, 577–593. [Google Scholar] [CrossRef]
  23. Leanza, L.; Trentin, L.; Becker, K.A.; Frezzato, F.; Zoratti, M.; Semenzato, G.; Gulbins, E.; Szabo, I. Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia. Leukemia 2013, 27, 1782–1785. [Google Scholar] [CrossRef]
  24. Panyi, G.; Vamosi, G.; Bacso, Z.; Bagdany, M.; Bodnar, A.; Varga, Z.; Gaspar, R.; Matyus, L.; Damjanovich, S. Kv1.3 potassium channels are localized in the immunological synapse formed between cytotoxic and target cells. Proc. Natl. Acad. Sci. USA 2004, 101, 1285–1290. [Google Scholar] [CrossRef] [PubMed]
  25. Kemmer, G.; Keller, S. Nonlinear least-squares data fitting in Excel spreadsheets. Nat. Protoc. 2010, 5, 267–281. [Google Scholar] [CrossRef] [PubMed]
  26. Villalonga, N.; David, M.; Bielańska, J.; González, T.; Parra, D.; Soler, C.; Comes, N.; Valenzuela, C.; Felipe, A. Immunomodulatory effects of diclofenac in leukocytes through the targeting of Kv1.3 voltage-dependent potassium channels. Biochem. Pharmacol. 2010, 80, 858–866. [Google Scholar] [CrossRef] [PubMed]
  27. Doebler, J.A. Effects of neutral ionophores on membrane electrical characteristics of NG108-15 cells. Toxicol. Lett. 2000, 114, 27–38. [Google Scholar] [CrossRef]
  28. Wu, S.N.; Huang, Y.M.; Liao, Y.K. Effects of ibandronate sodium, a nitrogen-containing bisphosphonate, on intermediate-conductance calcium-activated potassium channels in osteoclast precursor cells (RAW 264.7). J. Membr. Biol. 2015, 248, 103–115. [Google Scholar] [CrossRef]
  29. Sanna, M.G.; Liao, J.; Jo, E.; Alfonso, C.; Ahn, M.Y.; Peterson, M.S.; Webb, B.; Lefebvre, S.; Chun, J.; Gray, N.; et al. Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J. Biol. Chem. 2004, 279, 13839–13848. [Google Scholar] [CrossRef]
  30. Garland, C.J.; Smirnov, S.V.; Bagher, P.; Lim, C.S.; Huang, C.Y.; Mitchell, R.; Stanley, C.; Pinkney, A.; Dora, K.A. TRPM4 inhibitor 9-phenanthrol activates endothelial cell intermediate conductance calcium-activated potassium channels in rat isolated mesenteric artery. Br. J. Pharmacol. 2015, 172, 1114–1123. [Google Scholar] [CrossRef]
  31. Huang, M.H.; Huang, Y.M.; Wu, S.N. The Inhibition by Oxaliplatin, a Platinum-Based Anti-Neoplastic Agent, of the Activity of Intermediate-Conductance Ca(2)(+)-Activated K(+) Channels in Human Glioma Cells. Cell Physiol. Biochem. 2015, 37, 1390–1406. [Google Scholar] [CrossRef] [PubMed]
  32. Wu, S.N.; Hsu, M.C.; Liao, Y.K.; Wu, F.T.; Jong, Y.J.; Lo, Y.C. Evidence for inhibitory effects of flupirtine, a centrally acting analgesic, on delayed rectifier k(+) currents in motor neuron-like cells. Evid. Based Complementary Altern. Med. 2012, 2012, 148403. [Google Scholar] [CrossRef] [PubMed]
  33. Smaili, S.S.; Russell, J.T. Permeability transition pore regulates both mitochondrial membrane potential and agonist-evoked Ca2+ signals in oligodendrocyte progenitors. Cell Calcium 1999, 26, 121–130. [Google Scholar] [CrossRef] [PubMed]
  34. Matsumura, M.; Tsuchida, M.; Isoyama, N.; Takai, K.; Matsuyama, H. FTY720 mediates cytochrome c release from mitochondria during rat thymocyte apoptosis. Transpl. Immunol. 2010, 23, 174–179. [Google Scholar] [CrossRef]
  35. Kapoor, V.N.; Shin, H.M.; Cho, O.H.; Berg, L.J.; Kang, J.; Welsh, R.M. Regulation of tissue-dependent differences in CD8+ T cell apoptosis during viral infection. J. Virol. 2014, 88, 9490–9503. [Google Scholar] [CrossRef]
  36. Kovarik, J.M.; Schmouder, R.; Barilla, D.; Riviere, G.J.; Wang, Y.; Hunt, T. Multiple-dose FTY720: Tolerability, pharmacokinetics, and lymphocyte responses in healthy subjects. J. Clin. Pharmacol. 2004, 44, 532–537. [Google Scholar] [CrossRef] [PubMed]
  37. Coppi, E.; Cherchi, F.; Fusco, I.; Dettori, I.; Gaviano, L.; Magni, G.; Catarzi, D.; Colotta, V.; Varano, F.; Rossi, F.; et al. Adenosine A2B receptors inhibit K(+) currents and cell differentiation in cultured oligodendrocyte precursor cells and modulate sphingosine-1-phosphate signaling pathway. Biochem. Pharmacol. 2020, 177, 113956. [Google Scholar] [CrossRef]
  38. Shen, A.Y.; Tsai, J.H.; Teng, H.C.; Huang, M.H.; Wu, S.N. Inhibition of intermediate-conductance Ca2+-activated K+ channel and cytoprotective properties of 4-piperidinomethyl-2-isopropyl-5-methylphenol. J. Pharm. Pharmacol. 2007, 59, 679–685. [Google Scholar] [CrossRef] [PubMed]
  39. Wu, S.N.; Yu, H.S.; Jan, C.R.; Li, H.F.; Yu, C.L. Inhibitory effects of berberine on voltage- and calcium-activated potassium currents in human myeloma cells. Life Sci. 1998, 62, 2283–2294. [Google Scholar] [CrossRef]
  40. Essin, K.; Salanova, B.; Kettritz, R.; Sausbier, M.; Luft, F.C.; Kraus, D.; Bohn, E.; Autenrieth, I.B.; Peschel, A.; Ruth, P.; et al. Large-conductance calcium-activated potassium channel activity is absent in human and mouse neutrophils and is not required for innate immunity. Am. J. Physiol. Cell Physiol. 2007, 293, 45–54. [Google Scholar] [CrossRef][Green Version]
Sample Availability: Samples of the compounds are available upon the reasonable request to the corresponding author.
Molecules 25 04525 g001
Figure 1. Inhibitory effect of FTY720 on delayed-rectifier K+ current (IK(DR)) in Jurkat T-lymphocytes. In these experiments, cells were immersed in Ca2+-free Tyrode’s solution, the recording pipette was filled with a K+-containing solution, and the ramp pulses from −90 to +90 mV with a duration of 1 sec were applied. (A) Superimposed current traces in response to ramp pulse obtained in the absence (a) and presence of 0.3 μM, 1 μM and 3 μM FTY720. (B) Concentration-response curve of FTY720-induced inhibition of IK(DR) appearing in these cells. The smooth line represents the best fit to the modified Hill equation as described under Materials and Methods. The IC50 value, maximally inhibited percentage of IK(DR), and Hill coefficient for FTY720-induced inhibition of IK(DR) were 1.51 μM, 95% (i.e., a = 0.05) and 1.1, respectively. Each point represents the mean ± SEM (n = 9–13).
Figure 1. Inhibitory effect of FTY720 on delayed-rectifier K+ current (IK(DR)) in Jurkat T-lymphocytes. In these experiments, cells were immersed in Ca2+-free Tyrode’s solution, the recording pipette was filled with a K+-containing solution, and the ramp pulses from −90 to +90 mV with a duration of 1 sec were applied. (A) Superimposed current traces in response to ramp pulse obtained in the absence (a) and presence of 0.3 μM, 1 μM and 3 μM FTY720. (B) Concentration-response curve of FTY720-induced inhibition of IK(DR) appearing in these cells. The smooth line represents the best fit to the modified Hill equation as described under Materials and Methods. The IC50 value, maximally inhibited percentage of IK(DR), and Hill coefficient for FTY720-induced inhibition of IK(DR) were 1.51 μM, 95% (i.e., a = 0.05) and 1.1, respectively. Each point represents the mean ± SEM (n = 9–13).
Molecules 25 04525 g001
Molecules 25 04525 g002
Figure 2. Evaluation of the inactivation kinetics of FTY720-induced block of IK(DR) in Jurkat T-lymphocytes. In (A), the time courses of current inactivation in the absence (a) and presence of 0.3 μM (b), 1 μM (c) and 3 μM (d) FTY720 were well fitted by a single exponential as indicated in (B). Inset in (A) indicates the voltage protocol used. In (C), the kinetics of FTY-720-induced block of IK(DR) in Jurkat T-lymphocytes was evaluated. The reciprocal of inactivation time constant of IK(DR) (i.e., 1/τinact) taken by exponential fits of the trajectory of IK(DR) inactivation was constructed and plotted as a function of the FTY720 concentration (mean ± SEM; n = 8–10 for each point). Data points were well fitted by linear regression, indicating that FTY720-induced blocking tends to occur with a molecularity of 1. Blocking (k+1) and unblocking (k−1) rate constants, respectively derived from the slope and the y-axis intercept of the interpolated line, were estimated to be 1.0046 sec−1μM−1 and 3.1558 sec−1, respectively.
Figure 2. Evaluation of the inactivation kinetics of FTY720-induced block of IK(DR) in Jurkat T-lymphocytes. In (A), the time courses of current inactivation in the absence (a) and presence of 0.3 μM (b), 1 μM (c) and 3 μM (d) FTY720 were well fitted by a single exponential as indicated in (B). Inset in (A) indicates the voltage protocol used. In (C), the kinetics of FTY-720-induced block of IK(DR) in Jurkat T-lymphocytes was evaluated. The reciprocal of inactivation time constant of IK(DR) (i.e., 1/τinact) taken by exponential fits of the trajectory of IK(DR) inactivation was constructed and plotted as a function of the FTY720 concentration (mean ± SEM; n = 8–10 for each point). Data points were well fitted by linear regression, indicating that FTY720-induced blocking tends to occur with a molecularity of 1. Blocking (k+1) and unblocking (k−1) rate constants, respectively derived from the slope and the y-axis intercept of the interpolated line, were estimated to be 1.0046 sec−1μM−1 and 3.1558 sec−1, respectively.
Molecules 25 04525 g002
Molecules 25 04525 g003
Figure 3. Effect of FTY720 on steady-state inactivation of IK(DR) recorded from Jurkat T-lymphocytes. (A) Superimposed current traces obtained in the control. The conditioning voltage pulses with a duration of 1 sec to various membrane potentials ranging from −50 to +30 mV in 10-mV increments were applied from a holding potential of −50 mV. Following each conditioning pulse, a test pulse to +50 mV with a duration of 1 sec was applied to elicit IK(DR). The upper part indicates the voltage protocol applied. (B) Steady-state inactivation curves of IK(DR) taken in the absence (□) and presence (■) of 3 μM FTY720 (mean ± SEM; n = 7–10 for each point). Note that the presence of FTY720 shifts the midpoint of the inactivation curve toward hyperpolarizing voltage with no clear change in the slope factor.
Figure 3. Effect of FTY720 on steady-state inactivation of IK(DR) recorded from Jurkat T-lymphocytes. (A) Superimposed current traces obtained in the control. The conditioning voltage pulses with a duration of 1 sec to various membrane potentials ranging from −50 to +30 mV in 10-mV increments were applied from a holding potential of −50 mV. Following each conditioning pulse, a test pulse to +50 mV with a duration of 1 sec was applied to elicit IK(DR). The upper part indicates the voltage protocol applied. (B) Steady-state inactivation curves of IK(DR) taken in the absence (□) and presence (■) of 3 μM FTY720 (mean ± SEM; n = 7–10 for each point). Note that the presence of FTY720 shifts the midpoint of the inactivation curve toward hyperpolarizing voltage with no clear change in the slope factor.
Molecules 25 04525 g003
Molecules 25 04525 g004
Figure 4. Effect of FTY720 on the recovery of IK(DR) from inactivation in Jurkat T-lymphocytes. Changes in currents were measured under two-step voltage-clamp conditions. Cells were depolarized from −50 to +50 mV with a duration of 150 msec and various interpulse durations were applied. (A) Superimposed current traces obtained in the presence of 3 μM FTY720. The upper part indicates the voltage protocol used. (B) Time courses for the recovery of IK(DR) from inactivation obtained in the absence (■) and presence of 1 μM (□) and 3 μM (○) FTY720. Each point represents the mean ± SEM (n = 6–8). Each smooth line is the best fit to the data.
Figure 4. Effect of FTY720 on the recovery of IK(DR) from inactivation in Jurkat T-lymphocytes. Changes in currents were measured under two-step voltage-clamp conditions. Cells were depolarized from −50 to +50 mV with a duration of 150 msec and various interpulse durations were applied. (A) Superimposed current traces obtained in the presence of 3 μM FTY720. The upper part indicates the voltage protocol used. (B) Time courses for the recovery of IK(DR) from inactivation obtained in the absence (■) and presence of 1 μM (□) and 3 μM (○) FTY720. Each point represents the mean ± SEM (n = 6–8). Each smooth line is the best fit to the data.
Molecules 25 04525 g004
Molecules 25 04525 g005
Figure 5. Excessive accumulative inactivation of IK(DR) during repetitive stimuli in the absence (○) and presence of 1 μM (□) and 3 μM (△) FTY720 recorded from Jurkat T-lymphocytes. Currents were obtained during 1-sec repetitive depolarizations to +50 mV from a holding potential of −50 mV. Notably, the presence of FTY720 increases the rate of excessive accumulative inactivation of IK(DR) in response to repetitive stimuli.
Figure 5. Excessive accumulative inactivation of IK(DR) during repetitive stimuli in the absence (○) and presence of 1 μM (□) and 3 μM (△) FTY720 recorded from Jurkat T-lymphocytes. Currents were obtained during 1-sec repetitive depolarizations to +50 mV from a holding potential of −50 mV. Notably, the presence of FTY720 increases the rate of excessive accumulative inactivation of IK(DR) in response to repetitive stimuli.
Molecules 25 04525 g005
Molecules 25 04525 g006
Figure 6. Effect of FTY720 on IK(DR) in Jurkat T-lymphocytes treated with SEW2871. Cells were preincubated with SEW2871 (3 μM) for 5 h. (A) Superimposed IK(DR) traces obtained in the (a) absence and presence of (b) 1 and (c) 3 μM FTY720. Inset indicates the voltage protocol used. (B) Averaged I-V relationships of IK(DR) in the absence (■) and presence (□) of 3 μM FTY720 (mean ± SEM; n = 8–10 for each point). In each cell examined, IK(DR) was elicited from −50 mV to different voltages ranging from −50 to +50 mV in 10-mV increments.
Figure 6. Effect of FTY720 on IK(DR) in Jurkat T-lymphocytes treated with SEW2871. Cells were preincubated with SEW2871 (3 μM) for 5 h. (A) Superimposed IK(DR) traces obtained in the (a) absence and presence of (b) 1 and (c) 3 μM FTY720. Inset indicates the voltage protocol used. (B) Averaged I-V relationships of IK(DR) in the absence (■) and presence (□) of 3 μM FTY720 (mean ± SEM; n = 8–10 for each point). In each cell examined, IK(DR) was elicited from −50 mV to different voltages ranging from −50 to +50 mV in 10-mV increments.
Molecules 25 04525 g006
Molecules 25 04525 g007
Figure 7. Effect of FTY720, 9-phenanthrol and FTY720 plus TRAM-34 on the activity of IKCa channels recorded from Jurkat T-lymphocytes. Cells were bathed in a high-K+ bathing solution containing 1.8 mM CaCl2. In these experiments, cell-attached current recordings were performed and the probabilities of channel openings at −60 mV with or without the addition of various agents were measured and compared. (A) Original single-channel current traces obtained in the control and during exposure to 1 μM or 3 μM FTY720. Downward deflection indicates the opening event of the IKCa channel. (B) Summary of the data showing the effect of FTY720, 9-phenanthrol, and FTY720 plus TRAM-34 on IKCa-channel activity in Jurkat T-lymphocytes. Values are means ± SEM for n = 8–11 cells in each bar. * Significantly different from control (P < 0.05) and # significantly different from FTY720 (3 μM) alone group (P < 0.05).
Figure 7. Effect of FTY720, 9-phenanthrol and FTY720 plus TRAM-34 on the activity of IKCa channels recorded from Jurkat T-lymphocytes. Cells were bathed in a high-K+ bathing solution containing 1.8 mM CaCl2. In these experiments, cell-attached current recordings were performed and the probabilities of channel openings at −60 mV with or without the addition of various agents were measured and compared. (A) Original single-channel current traces obtained in the control and during exposure to 1 μM or 3 μM FTY720. Downward deflection indicates the opening event of the IKCa channel. (B) Summary of the data showing the effect of FTY720, 9-phenanthrol, and FTY720 plus TRAM-34 on IKCa-channel activity in Jurkat T-lymphocytes. Values are means ± SEM for n = 8–11 cells in each bar. * Significantly different from control (P < 0.05) and # significantly different from FTY720 (3 μM) alone group (P < 0.05).
Molecules 25 04525 g007
Molecules 25 04525 g008
Figure 8. Effect of FTY720 on IK(DR) in NSC-34 neuronal cells. Cells were bathed in Ca2+-free Tyrode’s solution containing 1 μM tetrodotoxin and 0.5 mM CdCl2 and the recording pipette was filled with K+-containing solution. (A) Superimposed IK(DR) traces obtained in the absence (a) and presence of 1 μM (b) and 3 μM (c) FTY720. The inset indicates the voltage protocol used. (B) Averaged I-V relationship of IK(DR) in the absence (●) and presence (○) of 3 μM FTY720 (mean ± SEM; n = 7–10 for each point). The IK(DR) amplitude was measured at the end of each depolarizing pulse. Notably, cell exposure to FTY slightly deceased IK(DR) amplitude with no modifications in activation or inactivation kinetics of the current.
Figure 8. Effect of FTY720 on IK(DR) in NSC-34 neuronal cells. Cells were bathed in Ca2+-free Tyrode’s solution containing 1 μM tetrodotoxin and 0.5 mM CdCl2 and the recording pipette was filled with K+-containing solution. (A) Superimposed IK(DR) traces obtained in the absence (a) and presence of 1 μM (b) and 3 μM (c) FTY720. The inset indicates the voltage protocol used. (B) Averaged I-V relationship of IK(DR) in the absence (●) and presence (○) of 3 μM FTY720 (mean ± SEM; n = 7–10 for each point). The IK(DR) amplitude was measured at the end of each depolarizing pulse. Notably, cell exposure to FTY slightly deceased IK(DR) amplitude with no modifications in activation or inactivation kinetics of the current.
Molecules 25 04525 g008

Share and Cite

MDPI and ACS Style

Chang, W.-T.; Liu, P.-Y.; Wu, S.-N. Actions of FTY720 (Fingolimod), a Sphingosine-1-Phosphate Receptor Modulator, on Delayed-Rectifier K+ Current and Intermediate-Conductance Ca2+-Activated K+ Channel in Jurkat T-Lymphocytes. Molecules 2020, 25, 4525. https://doi.org/10.3390/molecules25194525

AMA Style

Chang W-T, Liu P-Y, Wu S-N. Actions of FTY720 (Fingolimod), a Sphingosine-1-Phosphate Receptor Modulator, on Delayed-Rectifier K+ Current and Intermediate-Conductance Ca2+-Activated K+ Channel in Jurkat T-Lymphocytes. Molecules. 2020; 25(19):4525. https://doi.org/10.3390/molecules25194525

Chicago/Turabian Style

Chang, Wei-Ting, Ping-Yen Liu, and Sheng-Nan Wu. 2020. "Actions of FTY720 (Fingolimod), a Sphingosine-1-Phosphate Receptor Modulator, on Delayed-Rectifier K+ Current and Intermediate-Conductance Ca2+-Activated K+ Channel in Jurkat T-Lymphocytes" Molecules 25, no. 19: 4525. https://doi.org/10.3390/molecules25194525

APA Style

Chang, W.-T., Liu, P.-Y., & Wu, S.-N. (2020). Actions of FTY720 (Fingolimod), a Sphingosine-1-Phosphate Receptor Modulator, on Delayed-Rectifier K+ Current and Intermediate-Conductance Ca2+-Activated K+ Channel in Jurkat T-Lymphocytes. Molecules, 25(19), 4525. https://doi.org/10.3390/molecules25194525

Article Metrics

Back to TopTop